Ralph Moss: Big Pharma rules to get looser with new puppet to head FDA

[Guest guest]

16 Apr 2006 23:20:10 -0000

" Cancer Decisions " <

THE MOSS REPORTS Newsletter (04/16/06)

 

 

 

 

----------------------

Ralph W. Moss, Ph.D. Weekly CancerDecisions.com

Newsletter #232 04/16/06

----------------------

 

 

 

A NEW SPECIAL REPORT IS LAUNCHED

 

 

 

In our latest special report, The Politics of Hope - Andrew von

Eschenbach and the Decline of the National Cancer Institute, we

investigate one of the most Quixotic figures in the world of American

medicine.

During his four-year tenure as Director of the National Cancer

Institute (NCI), Andrew von Eschenbach embarrassed many of his peers

with his bizarre announcement that the suffering and death due to

cancer could, and would, be eliminated by the year 2015. To those who

have worked industriously for decades towards that elusive goal, von

Eschenbach's assertion seemed both fantastic and inappropriate.

Thirty-five years after the War on Cancer was declared by Congress,

and despite countless billions spent on research, no cure is even

remotely in view. What can have possessed von Eschenbach to make such

a prediction?

 

During his term at the National Cancer Institute, von Eschenbach has

played a pivotal role in reaffirming and reinforcing the unhealthy

intimacy between Big Pharma (the major multinational drug companies)

and the medical research establishment. Since von Eschenbach is now

officially nominated to take over the Food and Drug Administration

(FDA), the body responsible for licensing and approving all drugs for

use in medical practice, this connection is set to become even closer.

 

Indeed, there is a growing body of evidence to suggest that von

Eschenbach and his appointees and associates are strongly inclined

towards reshaping the drug approval process in such a way as to relax

existing criteria for effectiveness. Easing of existing demands for

stringency in testing could result in drugs being approved for the

treatment of cancer and other diseases with little or no evidence that

they actually prolong life or are any better than simple supportive care.

 

This latest report from Ralph W. Moss, PhD, is a detailed account of

the political forces behind von Eschenbach's bizarre assurances

concerning imminent victory in the War on Cancer, and the potentially

disastrous effects that von Eschenbach's philosophy and policies may

have should he become confirmed as the next head of the FDA.

 

The 29-page report is priced at $9.95 and can be downloaded directly

from our Web site, www.cancerdecisions.com.

 

To purchase a copy of The Politics of Hope - Andrew von Eschenbach and

the Decline of the National Cancer Institute, please click or go to:

https://webssl.cancerdecisions.com/list/optin.php?form_id=24